MedTrace Logo

Exercise Program for Early Breast Cancer Survivors

NCT01140282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2019-06-18

No results posted yet for this study

Summary

Rationale: Exercise therapy may improve the quality of life of breast cancer survivors.

Purpose: This randomized clinical trial studies exercise therapy and quality of life in postmenopausal early breast cancer survivors receiving aromatase inhibitor therapy.

Conditions

  • Stage I Breast Cancer
  • Stage II Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer

Interventions

OTHER

questionnaire administration

Administered within 3 days of baseline testing and at post-trial visit

PROCEDURE

quality-of-life assessment

Administered within 3 days of baseline testing and at post-trial visit

PROCEDURE

management of therapy complications

Assessed within 3 days of baseline testing and at post-trial visit

BEHAVIORAL

exercise intervention

12 week exercise intervention

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Southern California

    lead OTHER

Principal Investigators

  • Christina Dieli-Conwright, Ph.D. · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-21
Primary Completion
2017-09-28
Completion
2018-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01140282 on ClinicalTrials.gov